clearance

  • Briakinumab achieves 75% skin clearance rates

    In four separate pivotal clinical studies, a greater percentage of moderate to severe chronic plaque psoriasis patients treated with briakinumab, Abbott 's investigational IL-12/23 inhibitor (ABT-874), achieved 75 percent or better skin clearance rat…

    clearance | 19 November 2010

  • Marketing clearance for Heparin Lock Flush Solution, USP

    APP Pharmaceuticals announced that it has received clearance from the US FDA to market preservative-free Heparin Lock Flush Solution, USP in two dosage strengths, 10 USP Units/1 mL and 100 USP Units/1 mL, and will soon launch these single dose vial …

    clearance | 09 July 2010

  • Activaero Receives US FDA Clearance for Inhalation System

    Activaero has announced that the US Food and Drug Administration (FDA) has issued 510(K) Clearance for the company’s Akita Jet inhalation system. The clearance helps to pave the way for the company to utilize the device system in clinical trial…

    clearance | 31 December 2009

  • Sundia Speeds Up Customs Clearance in China

    Since the implementation of Express Customs Clearance on a trial basis for Sundia MediTech in Zhangjiang Hi-Tech Park in Shanghai, the customs clearance time for the company’s Contract Research Organization (CRO) shipments has been shortened from t…

    clearance | 13 August 2009

  • Arbor Vita Receives FDA Clearance for Flu Diagnostic

    Arbor Vita Corporation (AVC) has received 510(k) clearance from the US Food and Drug Administration for its AVantage A/H5N1 Flu Test. This is a non-invasive rapid diagnostic device for the specific detection of the avian influenza A/H5N1 virus in hum…

    clearance | 27 April 2009

  • Shionogi and Sciele receive US antitrust clearance

    Shionogi and Sciele Pharma announced that the waiting period under the Hart Scott Rodino Antitrust Improvements Act of 1976 on Shionogi’s indirect wholly owned subsidiary’s cash tender offer for all outstanding shares of common stock of Sciele at…

    clearance | 06 October 2008

  • Sun Pharma announces US FTC clearance for Taro tender offer

    The US Federal Trade Commission (FTC) has granted early termination of the antitrust waiting period on August 13 for the previously announced tender offer by Alkaloida Chemical Company Exclusive Group Ltd. (Alkaloida) for all outstanding ordinary sha…

    clearance | 22 August 2008